ADJUVANT GOSERELIN IN PRE-MENOPAUSAL PATIENTS WITH EARLY BREAST CANCER: RESULTS FROM THE ZIPP STUDY

• Main Authors: M. Baum (Author), A. Hackshaw (Author), J. Houghtona (Author), L. E. Rutqvist (Author), T. Fornander (Author), B. Nordenskjold (Author), A. Nicolucci (Author), R. Sainsburya (Author)
• Format: Book
• Published: ABV-press, 2014-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The Zoladex In Pre-menopausal Patients (ZIPP) study was designed to determine whether addition of goserelin ('Zoladex') and/or tamoxifen to adjuvant therapy (radiotherapy and/or chemotherapy), provided benefit to pre- or peri-menopausal women with operable, early breast cancer.